{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T21:32:08Z","timestamp":1781731928746,"version":"3.54.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s00520-025-09400-1","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T17:01:11Z","timestamp":1743699671000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association of GI symptoms with health-related quality of life in cancer patients undergoing chemotherapy: a prospective study"],"prefix":"10.1007","volume":"33","author":[{"given":"Ramadevi","family":"Obulapuram","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavan Kumar","family":"Narapaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chindu","family":"Esuru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2537-8889","authenticated-orcid":false,"given":"Sameer","family":"Dhingra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,1]]},"reference":[{"key":"9400_CR1","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1002\/cncr.33587","volume":"127","author":"F Bray","year":"2021","unstructured":"Bray F, Laversanne M, Weiderpass E, Soerjomataram I (2021) The ever-increasing importance of cancer as a leading cause of premature death worldwide. Cancer 127:3029\u20133030. https:\/\/doi.org\/10.1002\/cncr.33587","journal-title":"Cancer"},{"key":"9400_CR2","doi-asserted-by":"publisher","first-page":"205031212110343","DOI":"10.1177\/20503121211034366","volume":"9","author":"DT Debela","year":"2021","unstructured":"Debela DT, Muzazu SG, Heraro KD et al (2021) New approaches and procedures for cancer treatment: current perspectives. SAGE Open Med 9:20503121211034370. https:\/\/doi.org\/10.1177\/20503121211034366","journal-title":"SAGE Open Med"},{"key":"9400_CR3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0304-4858(03)74432-1","volume":"100","author":"J Ferreiro","year":"2003","unstructured":"Ferreiro J, Garc\u00eda JL, Barcel\u00f3 R, Rubio I (2003) Quimioterapia: efectos secundarios. Gac Med Bilbao 100:69\u201374","journal-title":"Gac Med Bilbao"},{"key":"9400_CR4","doi-asserted-by":"publisher","first-page":"204062232097035","DOI":"10.1177\/2040622320970354","volume":"11","author":"M O\u2019Reilly","year":"2020","unstructured":"O\u2019Reilly M, Mellotte G, Ryan B, O\u2019Connor A (2020) Gastrointestinal side effects of cancer treatments. Ther Adv Chronic Dis 11:2040622320970354. https:\/\/doi.org\/10.1177\/2040622320970354","journal-title":"Ther Adv Chronic Dis"},{"key":"9400_CR5","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/bs.acr.2022.02.007","volume":"155","author":"HI Akbarali","year":"2022","unstructured":"Akbarali HI, Muchhala KH, Jessup DK, Cheatham S (2022) Chemotherapy-induced gastrointestinal toxicities. Adv Cancer Res 155:131\u2013166. https:\/\/doi.org\/10.1016\/bs.acr.2022.02.007","journal-title":"Adv Cancer Res"},{"key":"9400_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.681417","volume":"12","author":"D Dahlgren","year":"2021","unstructured":"Dahlgren D, Sj\u00f6blom M, Hellstr\u00f6m PM, Lennern\u00e4s H (2021) Chemotherapeutics-induced intestinal mucositis: pathophysiology and potential treatment strategies. Front Pharmacol 12:681417. https:\/\/doi.org\/10.3389\/fphar.2021.681417","journal-title":"Front Pharmacol"},{"key":"9400_CR7","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1007\/s00520-020-05610-x","volume":"29","author":"HJN Andreyev","year":"2021","unstructured":"Andreyev HJN, Lalji A, Mohammed K et al (2021) The FOCCUS study: a prospective evaluation of the frequency, severity, and treatable causes of gastrointestinal symptoms during and after chemotherapy. Support Care Cancer 29:1443\u20131453. https:\/\/doi.org\/10.1007\/s00520-020-05610-x","journal-title":"Support Care Cancer"},{"key":"9400_CR8","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.3390\/biom13111586","volume":"13","author":"R Stavely","year":"2023","unstructured":"Stavely R, Ott LC, Rashidi N, Sakkal S, Nurgali K (2023) The oxidative stress and nervous distress connection in gastrointestinal disorders. Biomolecules 13:1586. https:\/\/doi.org\/10.3390\/biom13111586","journal-title":"Biomolecules"},{"key":"9400_CR9","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jgo.2018.08.010","volume":"10","author":"EB Moth","year":"2019","unstructured":"Moth EB, Kiely BE, Stefanic N et al (2019) Predicting chemotherapy toxicity in older adults: comparing the predictive value of the CARG Toxicity Score with oncologists\u2019 estimates of toxicity based on clinical judgment. J Geriatr Oncol 10:202\u2013209. https:\/\/doi.org\/10.1016\/j.jgo.2018.08.010","journal-title":"J Geriatr Oncol"},{"key":"9400_CR10","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000021695","volume":"99","author":"B Prieto-Callejero","year":"2020","unstructured":"Prieto-Callejero B, Rivera F, Fagundo-Rivera J et al (2020) Relationship between chemotherapy-induced adverse reactions and health-related quality of life in patients with breast cancer. Medicine 99:e21695. https:\/\/doi.org\/10.1097\/MD.0000000000021695","journal-title":"Medicine"},{"key":"9400_CR11","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1007\/s00520-011-1354-y","volume":"20","author":"E Mazzotti","year":"2012","unstructured":"Mazzotti E, Antonini Cappellini GC, Buconovo S, Morese R, Scoppola A, Sebastiani C, Marchetti P (2012) Treatment-related side effects and quality of life in cancer patients. Support Care Cancer 20:2553\u20132557","journal-title":"Support Care Cancer"},{"key":"9400_CR12","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1007\/s11136-018-1860-1","volume":"27","author":"IY Tantoy","year":"2018","unstructured":"Tantoy IY, Cooper BA, Dhruva A, Cataldo J, Paul SM, Conley YP, Hammer M, Kober KM, Levine JD, Miaskowski C (2018) Quality of life of patients with gastrointestinal cancers undergoing chemotherapy. Qual Life Res 27:1865\u20131876","journal-title":"Qual Life Res"},{"key":"9400_CR13","doi-asserted-by":"crossref","unstructured":"Toale KM, Johnson TN, Ma MQ. Chemotherapy-induced toxicities. In: Oncologic emergency medicine: principles and practice. 2016:381\u2013406.","DOI":"10.1007\/978-3-319-26387-8_33"},{"key":"9400_CR14","doi-asserted-by":"crossref","unstructured":"Kofoed S, Breen S, Gough K, Aranda S. Benefits of remote real-time side-effect monitoring systems for patients receiving cancer treatment. Oncol Rev 2012;6(1).","DOI":"10.4081\/oncol.2012.e7"},{"key":"9400_CR15","doi-asserted-by":"publisher","first-page":"1329220","DOI":"10.3389\/fphar.2024.1329220","volume":"15","author":"H Yan","year":"2024","unstructured":"Yan H, Wang P, Yang F, Cheng W, Chen C, Zhai B, Zhou Y (2024) Anticancer therapy-induced adverse drug reactions in children and preventive and control measures. Front Pharmacol 15:1329220","journal-title":"Front Pharmacol"},{"key":"9400_CR16","first-page":"131","volume":"1","author":"J Svedlund","year":"1988","unstructured":"Svedlund J, Sj\u00f6din I, Dotevall G (1988) GSRS - A clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Eur J Gastroenterol Hepatol 1:131\u2013136","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"9400_CR17","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"IC Framework","year":"1992","unstructured":"Framework IC, The MOS (1992) 36-item short-form health survey (SF-36). Med Care 30:473\u2013483","journal-title":"Med Care"},{"key":"9400_CR18","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1136\/bmj.315.7118.1273","volume":"315","author":"H Hemingway","year":"1997","unstructured":"Hemingway H, Stafford M, Stansfeld S, Shipley M, Marmot M (1997) Is the SF-36 a valid measure of change in population health? Results from the Whitehall II study. BMJ 315:1273\u20131279","journal-title":"BMJ"},{"key":"9400_CR19","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s11136-014-0785-6","volume":"24","author":"C Treanor","year":"2015","unstructured":"Treanor C, Donnelly M (2015) A methodological review of the Short Form Health Survey 36 (SF-36) and its derivatives among breast cancer survivors. Qual Life Res 24:339\u2013362","journal-title":"Qual Life Res"},{"key":"9400_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2458-8-1","volume":"8","author":"R Wang","year":"2008","unstructured":"Wang R, Wu C, Zhao Y, Yan X, Ma X, Wu M, Liu W, Gu Z, Zhao J, He J (2008) Health related quality of life measured by SF-36: a population-based study in Shanghai. China BMC Public Health 8:1\u20138","journal-title":"China BMC Public Health"},{"key":"9400_CR21","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s00520-013-2049-3","volume":"22","author":"TL Deshields","year":"2014","unstructured":"Deshields TL, Potter P, Olsen S, Liu J (2014) The persistence of symptom burden: symptom experience and quality of life of cancer patients across one year. Support Care Cancer 22:1089\u20131096","journal-title":"Support Care Cancer"},{"key":"9400_CR22","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1023\/A:1008841022998","volume":"7","author":"DA Revicki","year":"1997","unstructured":"Revicki DA, Wood M, Wiklund I, Crawley J (1997) Reliability and validity of the Gastrointestinal Symptom Rating Scale in patients with gastroesophageal reflux disease. Qual Life Res 7:75\u201383","journal-title":"Qual Life Res"},{"key":"9400_CR23","doi-asserted-by":"publisher","first-page":"11278","DOI":"10.7150\/thno.47289","volume":"10","author":"W Feng","year":"2020","unstructured":"Feng W, Liu J, Ao H, Yue S, Peng C (2020) Targeting gut microbiota for precision medicine: focusing on the efficacy and toxicity of drugs. Theranostics 10:11278","journal-title":"Theranostics"},{"key":"9400_CR24","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1084\/jem.20180448","volume":"216","author":"J Durack","year":"2019","unstructured":"Durack J, Lynch SV (2019) The gut microbiome: relationships with disease and opportunities for therapy. J Exp Med 216:20\u201340","journal-title":"J Exp Med"},{"key":"9400_CR25","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nrgastro.2017.20","volume":"14","author":"JL Alexander","year":"2017","unstructured":"Alexander JL, Wilson ID, Teare J, Marchesi JR, Nicholson JK, Kinross JM (2017) Gut microbiota modulation of chemotherapy efficacy and toxicity. Nat Rev Gastroenterol Hepatol 14:356\u2013365","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"9400_CR26","doi-asserted-by":"publisher","first-page":"153473542110617","DOI":"10.1177\/15347354211061733","volume":"20","author":"JM Deleemans","year":"2021","unstructured":"Deleemans JM, Gajtani Z, Baydoun M, Reimer RA, Piedalue KA, Carlson LE (2021) The use of prebiotic and probiotic interventions for treating gastrointestinal and psychosocial health symptoms in cancer patients and survivors: a systematic review. Integr Cancer Ther 20:15347354211061732","journal-title":"Integr Cancer Ther"},{"key":"9400_CR27","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e70","volume":"344","author":"DY Fong","year":"2012","unstructured":"Fong DY, Ho JW, Hui BP, Lee AM, Macfarlane DJ, Leung SS, Cerin E, Chan WY, Leung IP, Lam SH, Taylor AJ (2012) Physical activity for cancer survivors: meta-analysis of randomised controlled trials. BMJ 344:e70","journal-title":"BMJ"},{"key":"9400_CR28","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s00520-008-0519-9","volume":"17","author":"AM May","year":"2009","unstructured":"May AM, Korstjens I, van Weert E, van den Borne B, Hoekstra-Weebers JE, van der Schans CP, Mesters I, Passchier J, Grobbee DE, Ros WJ (2009) Long-term effects on cancer survivors\u2019 quality of life of physical training versus physical training combined with cognitive-behavioral therapy: results from a randomized trial. Support Care Cancer 17:653","journal-title":"Support Care Cancer"},{"key":"9400_CR29","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.3390\/jpm12081303","volume":"12","author":"Y Ilan","year":"2022","unstructured":"Ilan Y (2022) Next-generation personalized medicine: implementation of variability patterns for overcoming drug resistance in chronic diseases. J Pers Med 12:1303","journal-title":"J Pers Med"},{"key":"9400_CR30","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1136\/flgastro-2012-100218","volume":"4","author":"AC Muls","year":"2013","unstructured":"Muls AC, Watson L, Shaw C, Andreyev HJ (2013) Managing gastrointestinal symptoms after cancer treatment: a practical approach for gastroenterologists. Frontline Gastroenterol 4:57\u201368","journal-title":"Frontline Gastroenterol"},{"key":"9400_CR31","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1136\/gutjnl-2011-300563","volume":"61","author":"HJ Andreyev","year":"2012","unstructured":"Andreyev HJ, Davidson SE, Gillespie C, Allum WH, Swarbrick E (2012) Practice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancer. Gut 61:179\u2013192","journal-title":"Gut"},{"key":"9400_CR32","doi-asserted-by":"publisher","first-page":"4154","DOI":"10.3390\/cancers14174154","volume":"14","author":"W Misi\u0105g","year":"2022","unstructured":"Misi\u0105g W, Piszczyk A, Szyma\u0144ska-Chabowska A, Chabowski M (2022) Physical activity and cancer care\u2014a review. Cancers 14:4154","journal-title":"Cancers"},{"key":"9400_CR33","volume":"11","author":"K Lu","year":"2021","unstructured":"Lu K, Dong S, Wu X, Jin R, Chen H (2021) Probiotics in cancer. Front. Oncol 11:638148","journal-title":"Oncol"},{"key":"9400_CR34","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2165\/00019053-200119040-00003","volume":"19","author":"AM Rentz","year":"2001","unstructured":"Rentz AM, Battista C, Trudeau E, Jones R, Robinson P, Sloan S, Mathur S, Frank L, Revicki DA (2001) Symptom and health-related quality-of-life measures for use in selected gastrointestinal disease studies: a review and synthesis of the literature. Pharmacoeconomics 19:349\u2013363","journal-title":"Pharmacoeconomics"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09400-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-025-09400-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09400-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T07:10:43Z","timestamp":1745305843000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-025-09400-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["9400"],"URL":"https:\/\/doi.org\/10.1007\/s00520-025-09400-1","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"25 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This prospective study was conducted following the principles laid down in the Declaration of Helsinki and the ethical standards of the institute. The Ethics Committee of the Indian Council of Medical Research (ICMR)-Rajendra Memorial Research Institute of Medical Science (RMRIMS), Patna, Bihar, India, granted ethical approval for the study (RMRI\/EC\/29\/2023).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"336"}}